Learn More
Medchemexpress LLC Nanatinostat | 1256448-47-1 | 99.7% | C20H19FN6O2 | 10MG

Supplier: Medchemexpress LLC HY1343210MG
Nanatinostat is an orally bioavailable hydroxamic acid-based histone deacetylase (HDAC) inhibitor with reported antiproliferative and pro-apoptotic activity in cancer cell lines. Supplied as a research-grade compound with high purity, it is used in oncology and epigenetics studies and is available as solid vials and DMSO solution formats.
- Inhibits histone deacetylase (HDAC) activity.
- Demonstrates antiproliferative activity in cancer cell lines.
- Shows pro-apoptotic effects and induces cell cycle arrest.
- High purity suitable for research applications.
- Available as solid vials and DMSO solution for flexible dosing.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.